ReviewDrug design, development and therapy2026
Drug Repurposing for Metabolic-Associated Fatty Liver Disease: Current Evidence, Challenges, and Future Perspectives.
Xiaonan Liang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.